Francisco Guilherme Cancella Penna

11PUBLICATIONS
74CO-AUTHORS
Transplantation immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 06, 2026
Hepatocellular Expression of Macrophage Migration Inhibitory Factor (MIF) Is Associated with Ischemia-Reperfusion Injury After Liver Transplantation.

|Oct 16, 2025
Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Sep 10, 2025
EPIDEMIOLOGICAL AND CLINICAL PROFILE OF CROHN'S DISEASE IN A BRAZILIAN REFERRAL CENTER IN 30 YEARS OF FOLLOW-UP.

Igor Nolasco Segheto, Francisco Guilherme Cancella Penna, Sophia Campos Salles Silva de Carvalho

|Jul 18, 2025
Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Aug 29, 2024
COVID-19-Related Cholangiopathy: Histological Findings.

Valéria F A Borges, Helma P Cotrim, Antônio Ricardo C F Andrade

|Mar 30, 2023
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF ULCERATIVE COLITIS IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

Júlio Pinheiro Baima, Marcello Imbrizi, Adriana Ribas Andrade

Pageof 2

Frequent Collaborators

4 joint publications

Rogerio Serafim Parra

4 joint publications

Adriana Ribas Andrade

4 joint publications

Cristina Flores

4 joint publications

Renata de Sá Brito FrÓes